We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

900912:SSEShanghai Waigaoqiao Free Trade Zone Group Co., Ltd. Class B Analysis

Data as of 2026-05-31 - not real-time

$0.65

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Shanghai Waigaoqiao Free Trade Zone Group trades at a strikingly low PE of 6.5 versus an industry average near 30, and its price‑to‑book sits under 0.4, suggesting the stock is deeply undervalued. However, the balance sheet is heavily leveraged, with a debt‑to‑equity ratio exceeding 140, and free cash flow is negative, raising concerns about long‑term financial resilience. The company offers an attractive dividend yield of 7.4% and a payout ratio just under 50%, but the sustainability of that payout is questionable given the cash‑flow profile.
Technical indicators reinforce a cautious stance: the price sits below the 20‑day, 50‑day, and 200‑day SMAs, RSI is deep in oversold territory at around 28, and MACD shows a bearish divergence. Volume is stable but modest, and the stock is hovering near its recent support of 0.647, with limited upside to the 0.703 resistance. Combined with low beta and moderate 30‑day volatility, the equity presents a mixed risk picture—valuation upside is offset by financial and sector‑specific headwinds.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support with limited upside
  • RSI oversold but bearish MACD
  • High dividend yield may attract income seekers

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Undervalued valuation multiples relative to peers
  • Heavy debt load and negative free cash flow
  • Stable dividend payout but sustainability concerns

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount (low PE, PB, PS)
  • Potential upside if debt is restructured and cash flow improves
  • Attractive dividend yield for long‑term income

Key Metrics & Analysis

Financial Health

Revenue Growth-0.50%
Profit Margin15.25%
P/E Ratio6.5
ROE6.15%
ROA0.90%
Debt/Equity140.96
P/B Ratio0.4
Op. Cash Flow$434.6M
Free Cash Flow$-2627711232
Industry P/E29.9

Technical Analysis

TrendBearish
RSI28.3
Support$0.65
Resistance$0.70
MA 20$0.67
MA 50$0.68
MA 200$0.71
MACDBearish
VolumeStable
Fear & Greed Index94.07

Valuation

GradeUndervalued
TypeValue
Dividend Yield7.44%

Risk Assessment

Beta0.15
Volatility10.42%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.